Agena Bioscience, manufacturers of the MassARRAY quantitative method for nucleic acid detection via MALDI-TOF mass spectrometry, has set up a subsidiary in Shanghai, China. “The Chinese market represents a significant portion of Agena Bioscience's global sales with almost 60 MassARRAY® Systems installed to date. Direct presence within China will allow us to expand our reach and foster a high degree of engagement with our local customers in that region”, said Pete Dansky, CEO.
Bob Wang has joined Agena Bioscience as its Vice President and General Manager, Greater China. Bob most recently was Marketing Director for QIAGEN, responsible for leading the development of its molecular diagnostics and life science commercial strategies. Prior to this, Bob held senior positions encompassing Business Development, Marketing, Sales, and Regulatory Affairs at Hologic, Life Technologies, Applied Biosystems, and the Chinese Human Genome Center.
“We are delighted to have Bob leading our Greater China organization. His experience in both clinical diagnostics and life science research will help drive Agena Bioscience’s strategy and commercial execution in China”, said Dansky.
